RxDoctor Payments Data

Sumant Inamdar

Gastroenterology · Little Rock, ARNPI 1346472917

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (46.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Pentax Of America, Inc. at 50.5% of the total. Reporting peaked in 2023 at $3,247 and has fallen 79.7% since, to $659 in 2025.

$6,080in general payments, 2019–2025

Across 30 payments — averaging $202.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pentax Of America, Inc.$3K
  • Creo Medical Inc.$980
  • Boston Scientific$960
  • Olympus America Inc.$314
  • Conmed Corporation$235
  • Medtronic$209
  • plus $315 from 3 others

What the payments were for

  • Consulting fees$2,80046%
  • Travel & lodging$82514%
  • Food & beverage$2,45640%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,080 in reported general payments places this provider in the 70th percentile of 108 gastroenterology providers in Arkansas.

See all gastroenterology providers in Arkansas

Medicare billing

Part B allowed, 2024
$119,461
Medicare patients
335
Services billed
959

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sucralfate26$1,462
Omeprazole22$352
Pantoprazole Sodium26$174
Levofloxacin13$40

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →